Pharmaceutical delivery is the ideal electric vehicle duty cycle
Most fleet electrification projects fail on the same problem: the vehicle is asked to do a duty cycle it was not designed for. Long highway legs, uncertain daily mileage, unpredictable parking and no depot charging infrastructure will defeat any battery electric truck, regardless of how large the pack is.
Pharmaceutical and medical courier work is the opposite case. The routes are urban, the distances are predictable, the vehicle returns to the same depot every night, the loads are light relative to a diesel truck's capability, and the operator is measured on reliability and compliance rather than on top speed. It is close to a textbook electric duty cycle, and that is why it is usually the first application in a mixed fleet to convert.
The SAGMOTO i5 is configured for exactly this work. It is a battery electric light truck with approximately 98 kWh of lithium iron phosphate battery capacity, and it belongs to the SAGMOTO new energy electric trucks range. This guide covers the energy model for a pharma route, the temperature-controlled body specification, the compliance requirements that shape the build, and the economics against an equivalent diesel vehicle.
Why lithium iron phosphate suits this application
The i5 uses lithium iron phosphate, or LiFePO4, cell chemistry rather than the nickel-based chemistries common in passenger electric vehicles. That choice has three consequences that matter directly to a pharmaceutical distributor.
First, cycle life. LiFePO4 chemistry tolerates far more full charge and discharge cycles before capacity falls below the usable threshold, which is the right trade for a commercial vehicle that will be charged nightly for eight to ten years. Second, thermal stability. LFP cells are markedly more tolerant of high ambient temperature and of high state-of-charge parking, which matters in the Gulf, South Asia and African markets where a truck may sit in direct sun between drops. Third, safety profile. LFP chemistry is less prone to thermal runaway, which is a relevant consideration for a vehicle parked inside a depot building alongside other vehicles and stock.
The trade-off is energy density: an LFP pack weighs more than an equivalent nickel-based pack. For an urban delivery truck with a defined route, that trade is a good one. The i5 is not trying to maximise range at any cost; it is trying to deliver years of predictable daily service.
Route energy model: how far will a 98 kWh pack actually go?
The honest way to size an electric route is to build an energy budget per shift rather than to rely on a nominal range figure. Urban pharmaceutical delivery has a distinctive consumption profile: frequent stops, low average speed, meaningful idling at drop points, and a substantial auxiliary load from the refrigeration unit, which is the single largest non-propulsion consumer on the vehicle.
The table below gives an indicative energy budget for a representative urban pharma route. Figures assume a light-to-medium duty electric truck in the i5 class with a 98 kWh pack, a refrigerated compartment holding 2 to 8 degrees Celsius, and a mixed driving pattern of arterial roads and dense urban streets.
| Energy consumer | Indicative consumption | Basis | Share of 98 kWh pack |
|---|---|---|---|
| Traction, urban stop-start | 0.55 - 0.75 kWh per km | 120 km route | 66 - 90 kWh |
| Refrigeration unit, 2 to 8 C | 1.2 - 2.0 kWh per hour | 8-hour shift, hot climate | 10 - 16 kWh |
| Cab heating or air conditioning | 0.8 - 1.5 kWh per hour | 8-hour shift | 6 - 12 kWh |
| Door openings and load handling | 0.3 - 0.6 kWh per drop | 25 - 40 drops | 8 - 20 kWh |
| Reserve margin required | 15 percent of pack | Operational safety | 14.7 kWh |
Read together, the practical planning range for a refrigerated urban pharma route on a 98 kWh pack is roughly 110 to 170 km per shift depending on ambient temperature, drop density and driver behaviour. That is comfortably enough for the great majority of city pharmaceutical distribution, central medical store replenishment and clinic delivery rounds, and it is why the i5 converts so easily into this application.
Two variables move that number more than any other. Ambient temperature: in a hot climate the refrigeration unit and cab air conditioning together can consume a quarter of the pack before the truck moves. Drop density: a route with 40 short hops consumes more per kilometre than one with 12 longer hops, because acceleration from rest dominates the energy budget.
Regeneration changes the urban calculation
One property of electric drivetrains works strongly in favour of this application. Regenerative braking recovers a meaningful share of the energy otherwise lost in stop-start traffic, so an urban route with heavy congestion often shows better energy consumption per kilometre than a clear-running suburban route at higher average speed. A diesel courier vehicle performs worst in exactly the conditions where the i5 performs relatively best.
Temperature-controlled body specification
The body is where a pharmaceutical electric truck succeeds or fails commercially, and the specification is driven by the temperature band the products require.
| Product category | Required band | Body requirement | Monitoring requirement |
|---|---|---|---|
| Most vaccines and biologics | 2 to 8 C | Insulated compartment, active refrigeration | Continuous logging with alarm |
| Insulin and certain biologics | 2 to 8 C, no freezing | Tight control, no direct evaporator contact | Continuous logging, excursion alarm |
| Controlled ambient pharmaceuticals | 15 to 25 C | Insulated compartment, heating and cooling | Daily min-max record |
| Diagnostics and reagents | 2 to 8 C or frozen, per product | Dual-zone compartment | Zone-separate logging |
Three build items are worth insisting on. Insulation quality governs everything downstream: thicker, well-sealed panels with thermal breaks at the door frame reduce the refrigeration unit's duty cycle, which directly extends vehicle range. A dual-zone compartment with an independently controlled section lets one vehicle carry both refrigerated and ambient products without compromising either. And a bulkhead separating the refrigerated space from the cab and the ambient space prevents cold loss every time the driver accesses the load area.
On the refrigeration unit itself, specify electrically driven cooling sized for the worst ambient temperature on the route rather than for the annual average, with a standby capability that allows the compartment to hold temperature while the vehicle is parked during a long drop. Where the operation permits, pre-cooling the compartment while the vehicle is still plugged in at the depot removes a significant evening peak from the traction battery.
Data logging and chain of custody
Pharmaceutical distribution is audited, and the vehicle is part of the record. A compliant build should include a calibrated temperature data logger with a traceable certificate, continuous recording at an interval appropriate to the product, an audible and visual excursion alarm, and either a printed delivery record or an electronic export that integrates with the operator's quality system. Many tenders in this sector are lost on documentation capability rather than on price or vehicle specification, and it is far cheaper to build the logging in than to retrofit it.
Compliance, access and the zero-emission argument
Two external forces are pushing pharmaceutical distribution toward electric vehicles in city markets, and both are commercial rather than Environmental arguments.
The first is urban access. A growing number of cities operate low-emission or zero-emission zones that restrict diesel vehicles outright or charge them on entry. For a courier making 30 drops a day inside a restricted area, an access charge is a direct hit to cost per drop, and an outright restriction is a loss of the contract.
The second is customer procurement. Hospital groups, national health services and large pharmacy chains increasingly include emissions criteria in their distribution tenders, and some now score fleet emissions explicitly. A distributor bidding with an electric fleet is not merely compliant; in a scored tender it can win on a criterion the competitor cannot match with diesel.
Cost per drop: electric versus diesel
The table below sets out an indicative five-year comparison for an urban pharma courier route of 120 km and 30 drops per day, 250 operating days per year. Local electricity and diesel prices will move the result, so the model should be rerun with your own tariffs.
| Cost line | SAGMOTO i5 electric | Equivalent diesel light truck |
|---|---|---|
| Energy cost per 100 km | USD 4 - 8 (electricity) | USD 12 - 20 (diesel) |
| Annual energy cost, 30,000 km | USD 1,200 - 2,400 | USD 3,600 - 6,000 |
| Scheduled maintenance, annual | USD 700 - 1,300 | USD 1,800 - 3,000 |
| Unscheduled downtime, annual | 1 - 3 days | 4 - 8 days |
| Depot charging infrastructure, one-off | USD 3,000 - 9,000 per bay | Not required |
| Urban access charges in restricted zones | None | USD 800 - 3,500 per year |
The pattern that emerges across most markets is that the i5 wins on energy and maintenance, loses on the one-off charging infrastructure, and wins again on access charges where a low-emission zone applies. The crossover typically falls between year two and year three of ownership, and it arrives earlier in markets with high diesel prices, low electricity tariffs or an active urban access charge.
What should not be underestimated is the downtime line. A battery electric drivetrain has no oil changes, no fuel system, no exhaust aftertreatment, no gearbox service and far fewer wearing parts in the brake system because regeneration does much of the work. For a pharmaceutical distributor whose service level agreement carries penalties, availability is worth more than the fuel saving.
Depot and charging requirements
An electric pharmaceutical fleet needs surprisingly little infrastructure, provided the routes are genuinely predictable. Overnight depot charging on AC is sufficient for most urban pharma operations: a 98 kWh pack recovers comfortably within an eight to ten hour overnight window on a properly specified AC charger, and the vehicle is plugged in during the hours it would otherwise be parked anyway.
Three practical items should be planned before delivery. Confirm the depot's available electrical capacity and whether a supply upgrade is needed, because this is the item most likely to delay a project. Locate chargers where the refrigerated compartment can stay plugged in and pre-cooled before departure. And install basic energy monitoring per bay, because per-vehicle consumption data is what turns a first batch of electric trucks into a repeatable fleet decision.
Conclusion
The SAGMOTO i5 fits pharmaceutical and medical courier work because the application and the vehicle reward the same things. The route is urban, repeatable and depot-returning, which is what a 98 kWh lithium iron phosphate pack is designed for. The load is temperature-critical, which the insulated dual-zone body and continuous logging address. And the operating environment increasingly penalises diesel through access charges, procurement criteria and noise restrictions, all of which a zero-emission driveline removes.
The conversion decision should be made on a measured route rather than on a range figure. Take the daily distance, the drop count, the ambient temperature profile and the refrigeration duty, build the energy budget, and confirm it against a 15 percent reserve. Most urban pharmaceutical routes pass that test comfortably, and those that pass it will convert profitably.
Shaanxi Fenghan Trading Co., Ltd. supplies the i5 with destination-market body conversion, temperature-controlled compartment specification and calibrated logging equipment. Send your route distance, drop count and temperature band and the energy model will show whether the conversion pays in your market.